The evolving epidemiology of viral encephalitis

Current Opinion in Neurology

Volumn 19, Issue 4, 2006, Pages 350-357

  Sejvar, James J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Chandipura virus; Monkeypox; Transplant associated encephalitis; West Nile virus

Indexed keywords

BLOOD DONOR; BLOOD TRANSFUSION; CHANDIPURA VIRUS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; EPIDEMIC; EVIDENCE BASED MEDICINE; HUMAN; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOLECULAR EPIDEMIOLOGY; MONKEYPOX VIRUS; NONHUMAN; NORTH AMERICA; PUBLIC HEALTH; RABIES VIRUS; REVIEW; RHABDOVIRUS; RISK FACTOR; SCREENING TEST; TRANSPLANTATION; VIRUS ENCEPHALITIS; VIRUS SURVIVAL; VIRUS TRANSMISSION; WEST NILE FLAVIVIRUS;

ANIMALS; ARBOVIRUSES; ENCEPHALITIS, VIRAL; HUMANS; MONKEYPOX VIRUS; VESICULOVIRUS; WEST NILE VIRUS;

EID: 33747351599     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wco.0000236613.74462.4c     Document Type: Review

References (80)

1. Nash D, Mostashari F, Fine A, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001; 344:1807-1814.
2. Hayes EB, Komar N, Nasci RS, et al. Epidemiology and transmission dynamics of West Nile virus disease. Emerg Infect Dis 2005; 11:1167-1173.
3. Watson JT, Pertel PE, Jones RC, et al. Clinical characteristics and functional outcomes of West Nile Fever. Ann Intern Med 2004; 141:360-365.
4. Emig M, Apple DJ. Severe West Nile virus disease in healthy adults. Clin Infect Dis 2004; 38:289-292.
5. Hayes EB. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis 2005; 11:1174-1179. A concise review of the vast amount of information recently published on WNV in North America.
6. Crichlow R, Bailey J, Gardner C. Cerebrospinal fluid neutrophilic pleocytosis in hospitalized West Nile virus patients. J Am Board Fam Pract 2004; 17:470-472.
7. Granwehr BP, Lillibridge KM, Higgs S, et al. West Nile virus: where are we now? Lancet Infect Dis 2004; 4:547-556.
8. O'Leary DR, Marfin AA, Montgomery SP, et al. The epidemic of West Nile virus in the United States, 2002. Vector Borne Zoonotic Dis 2004; 4:61-70.
9. Tyler KL, Pape J, Goody RJ, et al. CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitis. Neurology 2005; Dec 28 [Epub ahead of print] A summary of CSF findings in a large group of persons with West Nile neuroinvasive disease. Provides valuable information on the CSF parameters that is likely applicable to many viral central nervous system infections.
10. Sejvar JJ, Haddad MB, Tierney BC, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003; 290:511-515.
11. Solomon T, Vaughn DW. Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 2002; 267:171-194.
12. Pepperell C, Rau N, Krajden S, et al. West Nile virus infection in 2002: morbidity and mortality among patients admitted to hospital in southcentral Ontario. CMAJ 2003; 168:1399-1405.
13. Sejvar JJ, Leis AA, Stokic DS, et al. Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis 2003; 9:788-793.
14. Sejvar JJ, Bode AV, Marfin AA, et al. West Nile virus-associated flaccid paralysis. Emerg Infect Dis 2005; 11:1021-1027. A longitudinal study of a cohort of persons with WNV-associated paralysis, providing information on patterns of recovery, causes of mortality, and long-term outcome.
15. Li J, Loeb JA, Shy ME, et al. Asymmetric flaccid paralysis: a neuromuscular presentation of West Nile virus infection. Ann Neurol 2003; 53:703-710.
16. Leis AA, Stokic DS, Webb RM, et al. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003; 28:302-308.
17. Jeha LE, Sila CA, Lederman RJ, et al. West Nile virus infection: a new acute paralytic illness. Neurology 2003; 61:55-59.
18. Leis AA, Stokic DS, Polk JL, et al. A poliomyelitis-like syndrome from West Nile virus infection. N Engl J Med 2002; 347:1279-1280.
19. Solomon T, Willison H. Infectious causes of acute flaccid paralysis. Curr Opin Infect Dis 2003; 16:375-381.
20. Sejvar JJ. West Nile virus and "poliomyelitis". Neurology 2004; 63:206-207.
21. Cao NJ, Ranganathan C, Kupsky WJ, Li J. Recovery and prognosticators of paralysis in West Nile virus infection. J Neurol Sci 2005; 236:73-80. An important study assessing electrophysiologic features of WNV-associated paralysis and the potential prognostic indicators of recovery.
22. Green MS. Long-term death rates, West Nile Virus epidemic, Israel, 2000. Emerg Infect Dis 2005; 11:1754-1757.
23. Adelman RA, Membreno JH, Afshari NA, Stoessel KM. West Nile virus chorioretinitis. Retina 2003; 23:100-101.
24. Alpert SG, Fergerson J, Noel LP. Intrauterine West Nile virus: ocular and systemic findings. Am J Ophthalmol 2003; 136:733-735.
25. Bains HS, Jampol LM, Caughron MC, Parnell JR. Vitritis and chorioretinitis in a patient with West Nile virus infection. Arch Ophthalmol 2003; 121:205-207.
26. Gilad R, Lampl Y, Sadeh M, et al. Optic neuritis complicating West Nile virus meningitis in a young adult. Infection 2003; 31:55-56.
27. Hershberger VS, Augsburger JJ, Hutchins RK, et al. Chorioretinal lesions in nonfatal cases of West Nile virus infection. Ophthalmology 2003; 110:1732-1736.
28. Kulstad EB, Wichter MD. West Nile encephalitis presenting as a stroke. Ann Emerg Med 2003; 41:283.
29. Montgomery SP, Chow CC, Smith SW, et al. Rhabdomyolysis in patients with West Nile encephalitis and meningitis. Vector Borne Zoonotic Dis 2005; 5:252-257.
30. Medarov BI, Multz AS, Brown W, Lempert L. West Nile meningoencephalitis and rhabdomyolysis. Lancet Infect Dis 2005; 5:2.
31. Civen R, Villacorte F, Robles DT, et al. West Nile virus infection in the pediatric population. Pediatr Infect Dis J 2006; 25:75-78.
32. Debiasi RL, Parsons JA, Grabert BE. West Nile virus meningoencephalitis in an immunocompetent adolescent. Pediatr Neurol 2005; 33:217-219.
33. Hayes EB, O'Leary DR. West Nile virus infection: a pediatric perspective. Pediatrics 2004; 113:1375-1381.
34. Francisco AM, Glaser C, Frykman E, et al. 2004 California pediatric West Nile virus case series. Pediatr Infect Dis J 2006; 25:81-84.
35. Moon TD, Nadimpalli A, Martin EB, et al. Balance and gait abnormalities of a child with West Nile virus infection. Pediatr Infect Dis J 2005; 24:568-570.
36. Heresi GP, Mancias P, Mazur LJ, et al. Poliomyelitis-like syndrome in a child with West Nile virus infection. Pediatr Infect Dis J 2004; 23:788-789.
37. Petersen LR, Marfin AA, Gubler DJ. West Nile virus. JAMA 2003; 290:524-528.
38. Roehrig JT, Nash D, Maldin B, et al. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg Infect Dis 2003; 9:376-379.
39. Martin DA, Biggerstaff BJ, Allen B, et al. Use of immunoglobulin M cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States. Clin Diagn Lab Immunol 2002; 9:544-549.
40. Kapoor H, Signs K, Somsel P, et al. Persistence of West Nile virus (WNV) IgM antibodies in cerebrospinal fluid from patients with CNS disease. J Clin Virol 2004; 31:289-291.
41. Kalil AC, Devetten MP, Singh S, et al. Use of interferon-alpha in patients with West Nile encephalitis: report of 2 cases. Clin Infect Dis 2005; 40:764-766.
42. Anderson JF, Rahal JJ. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002; 8:107-108.
43. Leis AA, Stokic DS. Neuromuscular manifestations of human West Nile virus infection. Curr Treat Options Neurol 2005; 7:15-22.
44. Agrawal AG, Petersen LR. Human immunoglobulin as a treatment for West Nile virus infection. J Infect Dis 2003; 188:1-4.
45. Sejvar JJ, Campbell, Grant L. Arthropod-borne virus infections. In: Johnson RT, Griffin JW, MacArthur JC, editors. Current therapy in neurologic disease, 7th ed. Philadelphia: Mosby Elsevier; 2005. pp. 129-137.
46. Calisher CH. Medically important arboviruses of the United States and Canada. Clin Microbiol Rev 1994; 7:89-116.
47. Deresiewicz RL, Thaler SJ, Hsu L, Zamani AA. Clinical and neuroradiographic manifestations of eastern equine encephalitis. N Engl J Med 1997; 336:1867-1874.
48. Erwin PC, Jones TF, Gerhardt RR, et al. La Crosse encephalitis in Eastern Tennessee: clinical, environmental, and entomological characteristics from a blinded cohort study. Am J Epidemiol 2002; 155:1060-1065.
49. McJunkin JE, de los Reyes EC, Irazuzta JE, et al. La Crosse encephalitis in children. N Engl J Med 2001; 344:801-807.
50. Rust RS TW, Matthews CG, Beaty BJ, Chun RW. La Crosse and other forms of California encephalitis. J Child Neurol 1999; 14:1-14.
51. Balkhy HH, Schreiber JR. Severe La Crosse encephalitis with significant neurologic sequelae. Pediatr Infect Dis J 2000; 19:77-80.
52. Grabow JD, Matthews CG, Chun RW, Thompson WH. The electroencephalogram and clinical sequelae of California arbovirus encephalitis. Neurology 1969; 19:394-404.
53. Matthews CG CR, Grabow JD, Thompson WH. Psychological sequelae in children following California arbovirus encephalitis. Neurology 1968; 18:1023-1030.
54. Kile JC, Fleischauer AT, Beard B, et al. Transmission of monkeypox among persons exposed to infected prairie dogs in Indiana in 2003. Arch Pediatr Adolesc Med 2005; 159:1022-1025.
55. Sejvar JJ, Chowdary Y, Schomogyi M, et al. Human monkeypox infection: a family cluster in the midwestern United States. J Infect Dis 2004; 190:1833-1840.
56. Chatterjee P. Japanese encephalitis outbreak in India. Lancet Neurol 2005; 4:700.
57. Lam K, Tsang OT, Yung RW, Lau KK. Japanese encephalitis in Hong Kong. Hong Kong Med J 2005; 11:182-188.
58. Mackenzie JS. Emerging zoonotic encephalitis viruses: lessons from Southeast Asia and Oceania. J Neurovirol 2005; 11:434-440.
59. Mudur G. Japanese encephalitis outbreak kills 1300 children in India. BMJ 2005; 331:1288.
60. Bellini WJ, Harcourt BH, Bowden N, Rota PA. Nipah virus: an emergent paramyxovirus causing severe encephalitis in humans. J Neurovirol 2005; 11:481-487.
61. Chua KB, Koh CL, Hooi PS, et al. Isolation of Nipah virus from Malaysian Island flying-foxes. Microbes Infect 2002; 4:145-151.
62. Harcourt BH, Lowe L, Tamin A, et al. Genetic characterization of Nipah virus, Bangladesh, 2004. Emerg Infect Dis 2005; 11:1594-1597.
63. Lam SK, Chua KB. Nipah virus encephalitis outbreak in Malaysia. Clin Infect Dis 2002; 34 (Suppl 2):S48-S51.
64. Reynes JM, Counor D, Ong S, et al. Nipah virus in Lyle's flying foxes. Cambodia Emerg Infect Dis 2005; 11:1042-1047.
65. Tan CT, Tan KS. Nosocomial transmissibility of Nipah virus. J Infect Dis 2001; 184:1367.
66. Wong SC, Ooi MH, Wong MN, et al. Late presentation of Nipah virus encephalitis and kinetics of the humoral immune response. J Neurol Neurosurg Psychiatry 2001; 71:552-554.
67. Rao BL, Basu A, Wairagkar NS, et al. A large outbreak of acute encephalitis with high fatality rate in children in Andhra Pradesh, India, in 2003, associated with Chandipura virus. Lancet 2004; 364:869-874.
68. John TJ. Chandipura virus, encephalitis, and epidemic brain attack in India. Lancet 2004; 364:2175; author reply 2175-2176.
69. Chadha MS, Arankalle VA, Jadi RS, et al. An outbreak of Chandipura virus encephalitis in the eastern districts of Gujarat state. India Am J Trop Med Hyg 2005; 73:566-570.
70. Pealer LN, Marfin AA, Petersen LR, et al. Transmission of West Nile virus through blood transfusion in the United States in 2002. N Engl J Med 2003; 349:1236-1245.
71. Busch MP, Caglioti S, Robertson EF, et al. Screening the blood supply for West Nile virus RNA by nucleic acid amplification testing. N Engl J Med 2005; 353:460-467.
72. Macedo de Oliveira A, Beecham BD, Montgomery SP, et al. West Nile virus blood transfusion-related infection despite nucleic acid testing. Transfusion 2004; 44:1695-1699.
73. Custer B, Busch MP, Marfin AA, Petersen LR. The cost-effectiveness of screening the U.S. blood supply for West Nile virus. Ann Intern Med 2005; 143:486-492.
74. Iwamoto M, Jernigan DB, Guasch A, et al. Transmission of West Nile virus from an organ donor to four transplant recipients. N Engl J Med 2003; 348:2196-2203.
75. West Nile virus infections in organ transplant recipients: New York and Pennsylvania, August-September, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:1021-1023.
76. Srinivasan A, Burton EC, Kuehnert MJ, et al. Transmission of rabies virus from an organ donor to four transplant recipients. N Engl J Med 2005; 352:1103-1111.
77. Burton EC, Burns DK, Opatowsky MJ, et al. Rabies encephalomyelitis: clinical, neuroradiological, and pathological findings in 4 transplant recipients. Arch Neurol 2005; 62:873-882.
78. Willoughby RE Jr, Tieves KS, Hoffman GM, et al. Survival after treatment of rabies with induction of coma. N Engl J Med 2005; 352:2508-2514. Readers are left to draw their own conclusion as to the relative contributions of the therapies described in this report with respect to this case of rare survival of rabies encephalitis.
79. Jackson AC. Recovery from rabies. N Engl J Med 2005; 352:2549-2550.
80. Lymphocytic choriomeningitis virus infection in organ transplant recipients: Massachusetts, Rhode Island, 2005. MMWR Morb Mortal Wkly Rep 2005; 54:537-539.